Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Efficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-analysis

  • Marco Spadaccini*
  • , Leonardo Frazzoni
  • , Giuseppe Vanella
  • , James East
  • , Franco Radaelli
  • , Cristiano Spada
  • , Lorenzo Fuccio
  • , Robert Benamouzig
  • , Raf Bisschops
  • , Michael Bretthauer
  • , Evelien Dekker
  • , Mario Dinis-Ribeiro
  • , Monika Ferlitsch
  • , Ian Gralnek
  • , Rodrigo Jover
  • , Michal F Kaminski
  • , Maria Pellisé
  • , Konstantinos Triantafyllou
  • , Jeanin E Van Hooft
  • , Jean-Marc Dumonceau
  • Clelia Marmo, Sergio Alfieri, Viveksandeep Thoguluva Chandrasekar, Prateek Sharma, Doug K Rex, Alessandro Repici, Cesare Hassan
*Autore corrispondente per questo lavoro
  • Humanitas University
  • Alma Mater Studiorum University of Bologna
  • Sant'Andrea Hospital
  • Nihr Oxford Biomedical Research Centre
  • Ospedale Valduce
  • KU Leuven
  • University of Oslo
  • Academic Medical Center
  • Universidade Do Porto
  • Medical University of Vienna
  • Emek Medical Center
  • Hospital General Universitario de Alicante
  • Technion-Israel Institute of Technology
  • University of Barcelona
  • National and Kapodistrian University of Athens
  • University of Campania Luigi Vanvitelli
  • VA Medical Center
  • Ospedale Nuovo Regina Margherita

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

BACKGROUND & AIMS: Efficacy of bowel preparation is an important determinant of outcomes of colonoscopy. It is not clear whether approved low-volume polyethylene glycol (PEG) and non-PEG regimens are as effective as high-volume PEG regimens when taken in a split dose.METHODS: In a systematic review of multiple electronic databases through January 31, 2019 with a registered protocol (PROSPERO: CRD42019128067), we identified randomized controlled trials that compared low- vs high-volume bowel cleansing regimens, administered in a split dose, for colonoscopy. The primary efficacy outcome was rate of adequate bowel cleansing, and the secondary efficacy outcome was adenoma detection rate. Primary tolerability outcomes were compliance, tolerability, and willingness to repeat. We calculated relative risk (RR) and 95% CI values and assessed heterogeneity among studies by using the I-2 statistic. The overall quality of evidence was assessed using the GRADE framework.RESULTS: In an analysis of data from 17 randomized controlled trials, comprising 7528 patients, we found no significant differences in adequacy of bowel cleansing between the low- vs high-volume split-dose regimens (86.1% vs 87.4%; RR, 1.00; 95% CI, 0.98-1.02) and there was minimal heterogeneity (I-2 [17%). There was no significant difference in adenoma detection rate (RR, 0.96; 95% CI, 0.87-1.08) among 4 randomized controlled trials. Compared with high-volume, split-dose regimens, low-volume split-dose regimens had higher odds for compliance or completion (RR, 1.06; 95% CI, 1.02-1.10), tolerability (RR, 1.39; 95% CI, 1.12-1.74), and willingness to repeat bowel preparation (RR, 1.41; 95% CI, 1.20-1.66). The overall quality of evidence was moderate.CONCLUSIONS: Based on a systematic review of 17 randomized controlled trials, low-volume, split-dose regimens appear to be as effective as high-volume, split-dose regimens in bowel cleansing and are better tolerated, with superior compliance.
Lingua originaleInglese
pagine (da-a)1454-1465.e14
RivistaClinical Gastroenterology and Hepatology
Volume18
Numero di pubblicazione7
DOI
Stato di pubblicazionePubblicato - 2020

All Science Journal Classification (ASJC) codes

  • Epatologia
  • Gastroenterologia

Keywords

  • Adherence
  • Comparative
  • Endoscopy
  • Screening

Fingerprint

Entra nei temi di ricerca di 'Efficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-analysis'. Insieme formano una fingerprint unica.

Cita questo